Status:
COMPLETED
Improving Treatment Engagement for Adolescents With Bulimia Nervosa
Lead Sponsor:
Nova Scotia Health Authority
Conditions:
Eating Disorders
Eligibility:
All Genders
16-18 years
Phase:
NA
Brief Summary
Although 4.7% of adolescents suffer from symptoms of bulimia nervosa (BN), only 1/5 seek treatment. Hesitation to seek treatment is likely related to ego-syntonicity and fear of disclosing symptoms to...
Eligibility Criteria
Inclusion
- Adolescents with symptoms of BN (full threshold or subthreshold) defined by self-reported symptoms of binging and compensatory behaviours (self-induced vomiting, laxative abuse, diet pills, and diuretics). Excessive exercise and fasting will not be included due to the potential for subjectively in a self-report format.
- Ages of 16-18.
- Consent from the adolescent.
Exclusion
- Adolescent is actively engaged in psychological treatment for bulimia nervosa.
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2015
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT02252822
Start Date
September 1 2014
End Date
May 1 2015
Last Update
November 18 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Capital Health District Health Authority
Halifax, Nova Scotia, Canada, B3H2E2